drugset / Trial / NCT05623059

Evaluate Pharmacokinetics and Safety of Slow Release DHEA

NCT05623059 ↗

Non-randomizedSequentialOpen-labelTreatment

Summary

This is a study to look at pharmacokinetic levels of different doses of slow release DHEA in subjects with asthma.

Timeline

Start
2023-03-03
Primary completion
2025-04-24
Completion
2025-04-24

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject DHEA Unknown 50 mg Oral
Subject DHEA Unknown 100 mg Oral

Indications